Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 300

1.

Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence.

Mascilini F, Amadio G, Di Stefano MG, Ludovisi M, Di Legge A, Conte C, De Vincenzo R, Ricci C, Masciullo V, Salutari V, Scambia G, Ferrandina G.

Onco Targets Ther. 2014 Jul 12;7:1273-84. doi: 10.2147/OTT.S51550. eCollection 2014. Review.

PMID:
25050069
[PubMed]
Free PMC Article
2.

Survivin protein as predictor of pathologic response in patients with locally advanced cervical cancer treated with chemoradiation followed by radical surgery.

Zannoni GF, Petrillo M, Vellone VG, Martinelli E, Chiarello G, Ferrandina G, Scambia G.

Hum Pathol. 2014 May 27. pii: S0046-8177(14)00223-8. doi: 10.1016/j.humpath.2014.03.022. [Epub ahead of print]

PMID:
24997647
[PubMed - as supplied by publisher]
3.

Evaluation of quality of life and emotional distress in endometrial cancer patients: a 2-year prospective, longitudinal study.

Ferrandina G, Petrillo M, Mantegna G, Fuoco G, Terzano S, Venditti L, Marcellusi A, De Vincenzo R, Scambia G.

Gynecol Oncol. 2014 Jun;133(3):518-25. doi: 10.1016/j.ygyno.2014.03.015. Epub 2014 Mar 14.

PMID:
24637198
[PubMed - indexed for MEDLINE]
4.

Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.

Pignata S, Scambia G, Katsaros D, Gallo C, Pujade-Lauraine E, De Placido S, Bologna A, Weber B, Raspagliesi F, Panici PB, Cormio G, Sorio R, Cavazzini MG, Ferrandina G, Breda E, Murgia V, Sacco C, Cinieri S, Salutari V, Ricci C, Pisano C, Greggi S, Lauria R, Lorusso D, Marchetti C, Selvaggi L, Signoriello S, Piccirillo MC, Di Maio M, Perrone F; Multicentre Italian Trials in Ovarian cancer (MITO-7); Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens et du sein (GINECO); Mario Negri Gynecologic Oncology (MaNGO); European Network of Gynaecological Oncological Trial Groups (ENGOT-OV-10); Gynecologic Cancer InterGroup (GCIG) Investigators.

Lancet Oncol. 2014 Apr;15(4):396-405. doi: 10.1016/S1470-2045(14)70049-X. Epub 2014 Feb 28.

PMID:
24582486
[PubMed - indexed for MEDLINE]
5.

Mesenteric lymph node involvement in advanced ovarian cancer patients undergoing rectosigmoid resection: prognostic role and clinical considerations.

Gallotta V, Fanfani F, Fagotti A, Chiantera V, Legge F, Alletti SG, Nero C, Margariti AP, Papa V, Alfieri S, Ciccarone F, Scambia G, Ferrandina G.

Ann Surg Oncol. 2014 Jul;21(7):2369-75. doi: 10.1245/s10434-014-3558-0. Epub 2014 Feb 21.

PMID:
24558070
[PubMed - in process]
6.

Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients.

Chiantera V, Rossi M, De Iaco P, Koehler C, Marnitz S, Ferrandina G, Legge F, Parazzini F, Scambia G, Schneider A, Vercellino GF.

Int J Gynecol Cancer. 2014 Jun;24(5):916-22. doi: 10.1097/IGC.0b013e3182a80aec.

PMID:
24442006
[PubMed - in process]
7.

Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience.

Gallotta V, Fagotti A, Fanfani F, Ferrandina G, Nero C, Costantini B, Alletti SG, Chiantera V, Ercoli A, Scambia G.

Surg Endosc. 2014 Jun;28(6):1808-15. doi: 10.1007/s00464-013-3390-9. Epub 2014 Jan 11.

PMID:
24414460
[PubMed - in process]
8.

Completion surgery after concomitant chemoradiation in locally advanced cervical cancer: a comprehensive analysis of pattern of postoperative complications.

Ferrandina G, Ercoli A, Fagotti A, Fanfani F, Gallotta V, Margariti AP, Salerno MG, Chiantera V, Legge F, Macchia G, Morganti AG, Valentini V, Scambia G.

Ann Surg Oncol. 2014 May;21(5):1692-9. doi: 10.1245/s10434-013-3471-y. Epub 2014 Jan 10.

PMID:
24407316
[PubMed - in process]
9.

Successful treatment of a young patient with locally advanced clear cell adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery.

Ferrandina G, Lucidi A, De Ninno M, Carbone A, Chiantera V, Morganti AG, Macchia G.

Gynecol Obstet Invest. 2014;77(1):64-7. doi: 10.1159/000356685. Epub 2013 Nov 27.

PMID:
24296792
[PubMed - in process]
10.

Burkitt's lymphoma of the breast metastatic to the ovary diagnosed during pregnancy.

Testa AC, De Blasis I, Di Legge A, Belli P, Hohaus S, Ferrandina G.

Ultrasound Obstet Gynecol. 2013 Sep;42(3):364-6. No abstract available.

PMID:
24137791
[PubMed - indexed for MEDLINE]
11.

Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison.

Macchia G, Cilla S, Morganti AG, Deodato F, Legge F, Piermattei A, Chiantera V, Scambia G, Valentini V, Ferrandina G.

Acta Oncol. 2014 Feb;53(2):251-8. doi: 10.3109/0284186X.2013.819997. Epub 2013 Sep 19.

PMID:
24050516
[PubMed - in process]
12.

Dose-dense FEC followed by dose-dense ixabepilone as neoadjuvant treatment for breast cancer patients: a feasibility study.

Clavarezza M, Bordonaro R, Daniele B, Ferrandina G, Barni S, Turazza M, Coati F, De Matteis A, De Placido S, Cognetti F, Olmeo NA, Carrozza F, Bruzzi P, Del Mastro L; Gruppo Italiano Mammella.

Oncologist. 2013;18(8):924-5. doi: 10.1634/theoncologist.2013-0222. Epub 2013 Aug 12. Erratum in: Oncologist. 2013;18(10):1149.

PMID:
23939283
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: impact on prognosis in a single institution experience.

Fagotti A, Vizzielli G, Fanfani F, Costantini B, Ferrandina G, Gallotta V, Gueli Alletti S, Tortorella L, Scambia G.

Gynecol Oncol. 2013 Nov;131(2):341-6. doi: 10.1016/j.ygyno.2013.08.005. Epub 2013 Aug 9.

PMID:
23938372
[PubMed - indexed for MEDLINE]
14.

Timing and pattern of recurrence in ovarian cancer patients with high tumor dissemination treated with primary debulking surgery versus neoadjuvant chemotherapy.

Petrillo M, Ferrandina G, Fagotti A, Vizzielli G, Margariti PA, Pedone AL, Nero C, Fanfani F, Scambia G.

Ann Surg Oncol. 2013 Nov;20(12):3955-60. doi: 10.1245/s10434-013-3091-6. Epub 2013 Jul 10.

PMID:
23838915
[PubMed - indexed for MEDLINE]
15.

Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial.

Deodato F, Cilla S, Macchia G, Caravatta L, Mignogna S, Massaccesi M, Picardi V, Digesu C, Sallustio G, Bonomo P, Piermattei A, Ferrandina G, Scambia G, Valentini V, Cellini N, Morganti AG.

Oncol Lett. 2013 Jun;5(6):1889-1896. Epub 2013 Mar 29.

PMID:
23833662
[PubMed]
Free PMC Article
16.

Pre-hysterectomy cone biopsy is able to predict response in locally advanced cervical cancer patients submitted to neo-adjuvant chemoradiation.

Fanfani F, Fagotti A, Gagliardi ML, Ferrandina G, Monterossi G, Gallotta V, Zannoni GF, Scambia G.

Eur J Surg Oncol. 2013 Sep;39(9):1025-9. doi: 10.1016/j.ejso.2013.06.003. Epub 2013 Jul 1.

PMID:
23827381
[PubMed - indexed for MEDLINE]
17.

Fertility-sparing surgery in ovarian cancer extended beyond the ovaries: a case report and review of the literature.

Petrillo M, Legge F, Ferrandina G, Monterisi A, Pedone Anchora L, Scambia G.

Gynecol Obstet Invest. 2014;77(1):1-5. doi: 10.1159/000353277. Epub 2013 Jun 22.

PMID:
23796887
[PubMed - in process]
18.

Ovarian cancer patients with localized relapse: clinical outcome and prognostic factors.

Petrillo M, Fagotti A, Ferrandina G, Fanfani F, Costantini B, Vizzielli G, Pedone Anchora L, Nero C, Margariti PA, Scambia G.

Gynecol Oncol. 2013 Oct;131(1):36-41. doi: 10.1016/j.ygyno.2013.06.020. Epub 2013 Jun 20.

PMID:
23791829
[PubMed - indexed for MEDLINE]
19.

Trabectedin as single agent in the salvage treatment of heavily treated ovarian cancer patients: a retrospective, multicenter study.

Ferrandina G, Salutari V, Vincenzi B, Marinaccio M, Naglieri E, Loizzi V, Carpano S, Amadio G, Tonini G, Scambia G, Lorusso D.

Gynecol Oncol. 2013 Sep;130(3):505-10. doi: 10.1016/j.ygyno.2013.06.008. Epub 2013 Jun 14.

PMID:
23774301
[PubMed - indexed for MEDLINE]
20.

Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis.

Mantegna G, Petrillo M, Fuoco G, Venditti L, Terzano S, Anchora LP, Scambia G, Ferrandina G.

BMC Cancer. 2013 Mar 18;13:127. doi: 10.1186/1471-2407-13-127.

PMID:
23506235
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk